Robert Naclerio to Double-Blind Method
This is a "connection" page, showing publications Robert Naclerio has written about Double-Blind Method.
Connection Strength
1.630
-
A clinical trial of a microcrystalline cellulose topical nasal spray on the acute response to allergen challenge. Am J Rhinol Allergy. 2016 Jul; 30(4):269-73.
Score: 0.101
-
Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen. J Allergy Clin Immunol. 2011 Jul; 128(1):219-21.
Score: 0.070
-
Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2011 Apr; 127(4):927-34.
Score: 0.070
-
A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010 09; 48(3):318-24.
Score: 0.067
-
Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol. 2009 Jun; 123(6):1342-8.
Score: 0.062
-
Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol. 2008 May; 121(5):1126-1132.e7.
Score: 0.057
-
Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2008 Mar; 100(3):194-9.
Score: 0.057
-
Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis. Allergy Asthma Proc. 2008 Jan-Feb; 29(1):24-8.
Score: 0.056
-
Effects of saline sprays on symptoms after endoscopic sinus surgery. Am J Rhinol. 2006 Mar-Apr; 20(2):191-6.
Score: 0.049
-
Increased nasal airflow with budesonide compared with desloratadine during the allergy season. Arch Otolaryngol Head Neck Surg. 2005 Mar; 131(3):223-8.
Score: 0.046
-
Treatment of nasal inflammation decreases the ability of subjects with asthma to condition inspired air. Am J Respir Crit Care Med. 2004 Oct 15; 170(8):863-9.
Score: 0.044
-
Lack of evidence for muscarinic type 2 receptor modulation of the human nasonasal reflex. J Allergy Clin Immunol. 2001 Jan; 107(1):194-5.
Score: 0.035
-
Ipratropium bromide increases the ability of the nose to warm and humidify air. Am J Respir Crit Care Med. 2000 Sep; 162(3 Pt 1):1031-7.
Score: 0.034
-
As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2000 Apr; 105(4):732-8.
Score: 0.033
-
Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP. Rhinology. 2020 Feb 01; 58(1):10-17.
Score: 0.032
-
Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy. 2020 01; 75(1):148-157.
Score: 0.032
-
Comparison of the response to histamine challenge of the nose and the maxillary sinus: effect of loratadine. J Appl Physiol (1985). 1999 Sep; 87(3):1038-47.
Score: 0.031
-
Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2447-2449.e2.
Score: 0.031
-
Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation. Am J Respir Crit Care Med. 1998 Mar; 157(3 Pt 1):899-906.
Score: 0.028
-
Nasal provocation with allergen induces a secondary serum IgE antibody response. J Allergy Clin Immunol. 1997 Oct; 100(4):505-10.
Score: 0.028
-
A double-blind study of the discontinuation of ragweed immunotherapy. J Allergy Clin Immunol. 1997 Sep; 100(3):293-300.
Score: 0.027
-
Effects of loratadine and terfenadine on the induced nasal allergic reaction. Arch Otolaryngol Head Neck Surg. 1996 Mar; 122(3):309-16.
Score: 0.025
-
Duration of action of intranasal atropine on methacholine-induced nasal secretions. Arch Otolaryngol Head Neck Surg. 1996 Mar; 122(3):321-3.
Score: 0.025
-
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial. JAMA. 2016 Feb 02; 315(5):469-79.
Score: 0.025
-
Inhibition of the response to nasal provocation with bradykinin by HOE-140: efficacy and duration of action. Can J Physiol Pharmacol. 1995 Jul; 73(7):820-6.
Score: 0.024
-
Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine. Am J Respir Crit Care Med. 1994 Jun; 149(6):1457-65.
Score: 0.022
-
The effect of terfenadine on unilateral nasal challenge with allergen. J Allergy Clin Immunol. 1994 Mar; 93(3):594-605.
Score: 0.021
-
Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions. Clin Exp Allergy. 1994 Mar; 24(3):288-90.
Score: 0.021
-
A pilot study of the effects of intranasal budesonide delivered by NasoNeb® on patients with perennial allergic rhinitis. Int Forum Allergy Rhinol. 2014 Jan; 4(1):43-8.
Score: 0.021
-
Effect of oxymetazoline on the early response to nasal challenge with antigen. J Allergy Clin Immunol. 1993 Nov; 92(5):767-70.
Score: 0.021
-
Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies. J Allergy Clin Immunol. 1993 Nov; 92(5):717-21.
Score: 0.021
-
Demonstration of bilateral cholinergic secretory response after unilateral nasal cold, dry air challenge. Rhinology. 1993 Sep; 31(3):97-100.
Score: 0.021
-
The effect of antihistamines on the immediate allergic response: a comparative review. Otolaryngol Head Neck Surg. 1993 Jun; 108(6):723-30.
Score: 0.020
-
Local application of atropine attenuates the upper airway reaction to cold, dry air. Am Rev Respir Dis. 1992 Aug; 146(2):340-6.
Score: 0.019
-
Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine. J Allergy Clin Immunol. 1992 Jun; 89(6):1065-75.
Score: 0.019
-
Evaluation of a bedtime dose of a combination antihistamine/analgesic/decongestant product on antigen challenge the next morning. Laryngoscope. 1992 Mar; 102(3):330-4.
Score: 0.019
-
The effect of azelastine on the early allergic response. Clin Exp Allergy. 1992 Feb; 22(2):289-95.
Score: 0.019
-
Additional properties of cetirizine, a new H1 antagonist. Allergy Proc. 1991 May-Jun; 12(3):187-91.
Score: 0.018
-
Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air. Am Rev Respir Dis. 1991 Apr; 143(4 Pt 1):761-5.
Score: 0.018
-
Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol. 1991 Apr; 87(4):855-66.
Score: 0.018
-
Phenol as an adjuvant anesthetic for tympanostomy tube insertion. Int J Pediatr Otorhinolaryngol. 1991 Feb; 21(1):51-8.
Score: 0.017
-
Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen. Clin Exp Allergy. 1990 Nov; 20(6):701-5.
Score: 0.017
-
Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis. 1990 Jul; 142(1):167-71.
Score: 0.017
-
The effect of a leukotriene antagonist on the early response to antigen. Otolaryngol Head Neck Surg. 1990 Mar; 102(3):219-24.
Score: 0.016
-
Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: effect of systemic corticosteroids and relationship to eosinophil influx. J Allergy Clin Immunol. 1989 Sep; 84(3):338-46.
Score: 0.016
-
The effect of cetirizine on early allergic response. Laryngoscope. 1989 Jun; 99(6 Pt 1):596-9.
Score: 0.015
-
The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment. Am Rev Respir Dis. 1988 Aug; 138(2):406-12.
Score: 0.015
-
Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest. 1987 Oct; 80(4):957-61.
Score: 0.014
-
Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. 1987 Jun 11; 316(24):1506-10.
Score: 0.013
-
Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2007 Jun; 119(6):1430-7.
Score: 0.013
-
Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2006 Feb; 132(2):164-72.
Score: 0.012
-
Theophylline reduces the response to nasal challenge with antigen. Am J Med. 1985 Dec 20; 79(6A):43-7.
Score: 0.012
-
Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004 Jan; 92(1):73-9.
Score: 0.011
-
Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2003 May; 129(5):557-62.
Score: 0.010
-
Effects of fexofenadine on the early response to nasal allergen challenge. Ann Allergy Asthma Immunol. 2002 Dec; 89(6):578-84.
Score: 0.010
-
Effects of intranasal azelastine on the response to nasal allergen challenge. Laryngoscope. 2002 Jan; 112(1):47-52.
Score: 0.009
-
Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction. Ann Allergy Asthma Immunol. 1997 Mar; 78(3):307-12.
Score: 0.007
-
Reflex activation of nasal secretion by unilateral inhalation of cold dry air. Am Rev Respir Dis. 1993 Dec; 148(6 Pt 1):1616-22.
Score: 0.005
-
Preinduction of anesthesia in children with rectally administered midazolam. Anesthesiology. 1991 Apr; 74(4):670-4.
Score: 0.004
-
A competitive kinin receptor antagonist, [DArg0, Hyp3, DPhe7]-bradykinin, does not affect the response to nasal provocation with bradykinin. Br J Clin Pharmacol. 1991 Mar; 31(3):287-94.
Score: 0.004
-
Responses to ragweed-pollen nasal challenge before and after immunotherapy. J Allergy Clin Immunol. 1989 Aug; 84(2):197-205.
Score: 0.004
-
Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation. JAMA. 1986 Jan 10; 255(2):225-9.
Score: 0.003